Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | COGT | PTGX | CRSP | ||
| Company | Cogent Biosciences Inc | Protagonist Therapeutics Inc | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 39.46 | 87.96 | 58.17 | ||
| High | 39.94 | 90.18 | 58.76 | ||
| Low | 38.20 | 87.54 | 56.01 | ||
| Latest | 38.77 | 89.65 | 56.88 | ||
| Change | -0.54 | +2.32 | -1.30 | ||
| % Change | -1.37% | +2.66% | -2.23% | ||
| Volume | 1,840,400 | 1,473,100 | 1,660,200 | ||
| 20-Day Average Volume | 4,775,625 | 916,390 | 2,493,060 | ||
| Previous Close | 39.31 | 87.33 | 58.18 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 35.59 | 85.79 | 53.31 | ||
| 20-Day Raw Stochastic | 90.85% | 91.52% | 75.40% | ||
| 20-Day Relative Strength | 77.45 | 64.25 | 49.66 | ||
| Weighted Alpha | +141.77 | +78.36 | +12.64 | ||
| Today's Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 96% Buy | 24% Buy | ||
| Last Month's Opinion | 80% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.61% since 11/28/25 | -0.39% since 11/28/25 | +6.38% since 11/28/25 | ||
| Low | 37.75 on 12/02/25 | 83.52 on 12/02/25 | 51.00 on 12/01/25 | ||
| High | 40.25 on 12/02/25 | 90.18 on 12/05/25 | 59.77 on 12/04/25 | ||
| 1-Month | |||||
| %Chg | +168.86% since 11/05/25 | +15.11% since 11/05/25 | -0.19% since 11/05/25 | ||
| Low | 13.93 on 11/07/25 | 76.70 on 11/07/25 | 48.02 on 11/21/25 | ||
| High | 41.27 on 11/28/25 | 90.85 on 11/26/25 | 59.77 on 12/04/25 | ||
| 3-Month | |||||
| %Chg | +197.09% since 09/05/25 | +48.11% since 09/05/25 | +3.68% since 09/05/25 | ||
| Low | 11.60 on 09/22/25 | 54.50 on 09/09/25 | 48.02 on 11/21/25 | ||
| High | 41.27 on 11/28/25 | 93.25 on 10/10/25 | 78.48 on 10/08/25 | ||
| 6-Month | |||||
| %Chg | +547.25% since 06/05/25 | +66.57% since 06/05/25 | +47.47% since 06/05/25 | ||
| Low | 6.11 on 06/06/25 | 49.38 on 07/08/25 | 39.58 on 06/06/25 | ||
| High | 41.27 on 11/28/25 | 93.25 on 10/10/25 | 78.48 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,519,956 | 5,604,559 | 5,420,665 | ||
| Shares Outstanding, K | 142,377 | 62,516 | 95,300 | ||
| Annual Sales | 0 | 434,430,000 | 37,310,000 | ||
| Annual Net Income | -255,860,000 | 275,190,000 | -366,250,000 | ||
| Last Quarter Sales | 0 | 4,710,000 | 890,000 | ||
| Last Quarter Net Income | -80,930,000 | -39,340,000 | -106,440,000 | ||
| 60-Month Beta | 0.50 | 2.19 | 1.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 11/07/25 | -0.62 on 11/06/25 | -1.17 on 11/10/25 | ||
| Latest Earnings Date | 11/11/25 | 11/06/25 | 11/11/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 140.85 | 0.00 | ||